Edward Y Chan, MD
Internal Medicine · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 2
- Since medical school
- 52 years
- University of California, San Francisco School of Medicine, 1974
Offices
2 locations · Chinese Hospital Association · 37 clinicians in this group
Hospitals listed: Chinese Hospital. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chan’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Chinese HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPatients rate it 3 of 5 · 64% would definitely recommend itOverall rating: 2 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Chinese Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 7 the same, 1 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 104 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.12 (0.64 to 1.61) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 28 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.6 · 71 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 66 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.7 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 569 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.44) · 766 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 749 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.34 (0.76 to 5.93) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.13 (0.4 to 3.85) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.3 (0.57 to 4.02) · 93 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.72 (0 to 18.54) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.04 (0.78 to 9.3) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.07 (0.55 to 3.59) · 58 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.12 (0 to 2.33) · 543 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.392 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 111 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 33 · 78 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 16.3 · 64 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 148 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.1 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.1) · 478 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 39 cases | No different | Jan 2024 – Dec 2024 |
What patients said (160 patients answered, 21% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 68% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 64% |
| Staff "always" explained possible side effects | 57% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
Original Medicare doctor bills
$33,571
Medicare paid this office $33,571 for 107 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 87 | $23,902 | $108 |
| New patient visit (60+ min) | 24 | $4,271 | $178 |
| Short return visit (20+ min) | 11 | $1,378 | $53 |
Who their Medicare patients are
107 Original Medicare patients in 2024. Average age 76 · Women 59% · Also on Medicaid 76% · Health risk score 1.68. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Cancer 39% · Diabetes 37% · Chronic kidney disease 34% · COPD 30% · Depression 18% · Heart failure 15% · Coronary heart disease 12% · Dementia 12% · Atrial fibrillation 11%.
The office billed $60,221, Medicare allowed $47,787 and paid $33,571; for 317 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 107 | 317 | 76 | 1.68 | $60,221 | $33,571 |
| 2023 | 121 | 320 | 76 | 1.38 | $63,543 | $35,971 |
| 2022 | 129 | 369 | 76 | 1.17 | $68,630 | $37,300 |
| 2021 | 117 | 362 | 77 | 1.54 | $61,980 | $35,486 |
| 2020 | 112 | 355 | 78 | 1.86 | $58,152 | $28,900 |
| 2019 | 179 | 671 | 79 | 1.75 | $114,925 | $59,780 |
| 2018 | 183 | 568 | 78 | 1.54 | $100,100 | $49,855 |
| 2017 | 194 | 667 | 77 | 1.80 | $115,130 | $58,845 |
| 2016 | 200 | 648 | 78 | 1.64 | $100,370 | $56,780 |
| 2015 | 215 | 677 | 77 | 1.60 | $103,125 | $59,867 |
| 2014 | 226 | 804 | 78 | 1.57 | $113,300 | $63,779 |
| 2013 | 278 | 987 | 78 | 1.63 | $137,645 | $76,815 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 91 | $22,797 | $108 |
| New patient visit (60+ min) | 35 | $6,876 | $196 |
| Short return visit (20+ min) | 15 | $1,633 | $54 |
2022: 4 services
| Return visit (30+ min) | 101 | $24,202 | $104 |
| New patient visit (60+ min) | 26 | $4,851 | $187 |
| Short return visit (20+ min) | 20 | $2,675 | $50 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $2,094 | $175 |
2021: 3 services
| Return visit (30+ min) | 76 | $20,947 | $109 |
| Short return visit (20+ min) | 27 | $4,416 | $60 |
| New patient visit (60+ min) | 12 | $2,359 | $197 |
2020: 4 services
| Return visit (30+ min) | 76 | $16,619 | $90 |
| New patient visit (60+ min) | 15 | $2,887 | $192 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $2,814 | $65 |
| Short return visit (20+ min) | 27 | $2,589 | $48 |
2019: 7 services
| Return visit (30+ min) | 117 | $29,682 | $100 |
| New patient visit (60+ min) | 41 | $7,645 | $186 |
| Short return visit (20+ min) | 46 | $6,185 | $49 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $4,586 | $66 |
| Return visit (30+ min) | 12 | $4,052 | $71 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $3,461 | $182 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $3,183 | $94 |
2018: 4 services
| Return visit (30+ min) | 117 | $24,399 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $7,782 | $93 |
| New patient visit (60+ min) | 39 | $6,926 | $178 |
| Short return visit (20+ min) | 40 | $6,181 | $50 |
2017: 4 services
| Return visit (30+ min) | 123 | $27,673 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $8,576 | $93 |
| Short return visit (20+ min) | 44 | $7,016 | $53 |
| New patient visit (60+ min) | 37 | $6,954 | $188 |
2016: 4 services
| Return visit (30+ min) | 130 | $31,223 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $8,568 | $93 |
| Short return visit (20+ min) | 39 | $6,440 | $52 |
| New patient visit (60+ min) | 32 | $5,809 | $182 |
2015: 6 services
| Return visit (30+ min) | 141 | $30,933 | $95 |
| New patient visit (60+ min) | 43 | $7,930 | $184 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $7,203 | $94 |
| Short return visit (20+ min) | 50 | $5,764 | $47 |
| Return visit (30+ min) | 13 | $3,597 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $2,339 | $65 |
2014: 7 services
| Return visit (30+ min) | 134 | $28,649 | $90 |
| Short return visit (20+ min) | 73 | $9,193 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 52 | $8,614 | $64 |
| Return visit (30+ min) | 15 | $7,305 | $70 |
| New patient visit (60+ min) | 23 | $4,324 | $188 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,527 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,670 | $93 |
2013: 6 services
| Return visit (30+ min) | 157 | $35,033 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 97 | $19,847 | $63 |
| Short return visit (20+ min) | 64 | $8,730 | $56 |
| New patient visit (60+ min) | 23 | $4,133 | $180 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $3,575 | $170 |
| Return visit (30+ min) | 14 | $3,528 | $68 |
Medicaid work
$3,070 in 2024
Medicaid paid $3,070 for 27 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 27 | $3,070 |
| 2024 | 27 | 1 | 13 | $3,070 |
| 2023 | 31 | 1 | 16 | $3,911 |
| 2022 | 139 | 4 | 15 | $1,634 |
| 2021 | 98 | 4 | 14 | $227 |
| 2020 | 250 | 7 | 22 | $861 |
| 2019 | 192 | 7 | 19 | $150 |
| 2018 | 118 | 5 | 14 | $0 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 31 | $3,911 |
2022
| Return visit (30+ min) | 55 | $1,634 |
| Most recent systolic blood pressure < 140 mmhg | 28 | $0 |
| Most recent diastolic blood pressure < 90 mmhg | 28 | $0 |
| Bp scrn perf rec interval | 28 | $0 |
2021
| Return visit (30+ min) | 13 | $227 |
| Most recent systolic blood pressure < 140 mmhg | 29 | $0 |
| Most recent diastolic blood pressure < 90 mmhg | 28 | $0 |
| Bp scrn perf rec interval | 28 | $0 |
2020
| Return visit (30+ min) | 41 | $861 |
| TOBACCO NON-USER | 15 | $0 |
| Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 19 | $0 |
| Most recent systolic blood pressure < 140 mmhg | 54 | $0 |
| Most recent diastolic blood pressure < 90 mmhg | 52 | $0 |
| Bp scrn perf rec interval | 52 | $0 |
| Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method | 17 | $0 |
2019
| Return visit (30+ min) | 19 | $150 |
| TOBACCO NON-USER | 21 | $0 |
| Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 22 | $0 |
| Most recent systolic blood pressure < 140 mmhg | 37 | $0 |
| Most recent diastolic blood pressure < 90 mmhg | 36 | $0 |
| Bp scrn perf rec interval | 36 | $0 |
| Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method | 21 | $0 |
2018
| TOBACCO NON-USER | 12 | $0 |
| Most recent systolic blood pressure < 140 mmhg | 31 | $0 |
| Most recent diastolic blood pressure < 90 mmhg | 31 | $0 |
| Bp scrn perf rec interval | 31 | $0 |
| Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method | 13 | $0 |
Drugs they prescribed that Part D paid
$2,249,871
Pharmacies billed $2,249,871 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (24 of 1,303) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
1,115 generic and fewer than 11 brand-name prescriptions · $2,249,871 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Tagrisso | 76 | $1,248,600 | $16,429 |
| Promacta | 25 | $394,802 | $15,792 |
| Sorafenib | 13 | $100,701 | $7,746 |
| Erlotinib | 14 | $34,400 | $2,457 |
| Abiraterone Acetate | 17 | $28,820 | $1,695 |
See all 29 drugs
| Tagrisso | 76 | $1,248,600 | $16,429 |
| Promacta | 25 | $394,802 | $15,792 |
| Sorafenib | 13 | $100,701 | $7,746 |
| Erlotinib | 14 | $34,400 | $2,457 |
| Abiraterone Acetate | 17 | $28,820 | $1,695 |
| Tamoxifen Citrate | 84 | $2,768 | $33 |
| Imatinib Mesylate | 23 | $2,195 | $95 |
| Atorvastatin | 93 | $1,342 | $14 |
| Hydroxyurea | 66 | $1,334 | $20 |
| Anastrozole | 77 | $1,168 | $15 |
| Metformin | 73 | $1,140 | $16 |
| Losartan | 80 | $964 | $12 |
| Spironolactone-Hctz | 22 | $936 | $43 |
| Glipizide | 17 | $740 | $44 |
| Glipizide Er | 16 | $562 | $35 |
| Amlodipine Besylate | 54 | $454 | $8 |
| Promethazine | 23 | $414 | $18 |
| Prednisone | 42 | $360 | $9 |
| Tamsulosin | 16 | $350 | $22 |
| Atenolol | 29 | $342 | $12 |
| Omeprazole | 20 | $303 | $15 |
| Allopurinol | 30 | $298 | $10 |
| Acetaminophen-Codeine | 16 | $257 | $16 |
| Alendronate | 11 | $196 | $18 |
| Famotidine | 18 | $191 | $11 |
| Metoprolol | 13 | $129 | $10 |
| Triamcinolone Acetonide | 18 | $110 | $6 |
| Levothyroxine | 11 | $69 | $6 |
| Albuterol Sulfate Hfa | 23 | $29 | $1 |
Year by year
| 2024 | 1,303 | 201 | 2% (24) | None | $2,249,871 |
| 2023 | 1,307 | 207 | 2% (28) | None | $1,859,570 |
| 2022 | 1,212 | 191 | 2% (18) | None | $573,979 |
| 2021 | 1,210 | 173 | 1% (13) | None | $613,537 |
| 2020 | 1,162 | 186 | 2% (22) | 10% | $964,925 |
| 2019 | 1,313 | 206 | 4% (48) | None | $797,294 |
| 2018 | 1,337 | 214 | 3% (40) | None | $1,121,547 |
| 2017 | 1,317 | 215 | 2% (25) | None | $938,047 |
| 2016 | 1,702 | 250 | 3% (43) | None | $1,034,787 |
| 2015 | 1,842 | 273 | 1% (25) | None | $942,354 |
| 2014 | 1,977 | 292 | 2% (33) | None | $1,021,292 |
| 2013 | 2,308 | 335 | 3% (65) | None | $993,971 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 32 drugs
| Tagrisso | 58 | $939,979 | $16,207 |
| Promacta | 25 | $370,413 | $14,817 |
| Imbruvica | 13 | $206,655 | $15,897 |
| Abiraterone Acetate | 25 | $66,283 | $2,651 |
| Imatinib Mesylate | 17 | $18,895 | $1,111 |
| Jardiance | 18 | $13,778 | $765 |
| Eliquis | 15 | $12,952 | $863 |
| Tamoxifen Citrate | 84 | $4,712 | $56 |
| Hydroxyurea | 76 | $2,852 | $38 |
| Spironolactone-Hctz | 39 | $1,968 | $50 |
| Atorvastatin | 89 | $1,620 | $18 |
| Metformin | 86 | $1,323 | $15 |
| Glipizide | 21 | $1,235 | $59 |
| Anastrozole | 61 | $1,070 | $18 |
| Losartan | 81 | $1,007 | $12 |
| Albuterol Sulfate Hfa | 29 | $834 | $29 |
| Amlodipine Besylate | 58 | $626 | $11 |
| Allopurinol | 24 | $443 | $18 |
| Omeprazole | 16 | $427 | $27 |
| Famotidine | 17 | $409 | $24 |
| Atenolol | 29 | $356 | $12 |
| Tamsulosin | 13 | $343 | $26 |
| Metoprolol | 17 | $342 | $20 |
| Glipizide Er | 13 | $313 | $24 |
| Prednisone | 32 | $295 | $9 |
| Acetaminophen-Codeine | 14 | $286 | $20 |
| Hydrocodone-Acetaminophen | 13 | $208 | $16 |
| Levothyroxine | 13 | $204 | $16 |
| Triamcinolone Acetonide | 16 | $181 | $11 |
| Hydrochlorothiazide | 17 | $113 | $7 |
| Ondansetron | 13 | $93 | $7 |
| Carvedilol | 11 | $88 | $8 |
2022: 29 drugs
| Abiraterone Acetate | 12 | $126,948 | $10,579 |
| Jardiance | 16 | $14,083 | $880 |
| Eliquis | 13 | $8,881 | $683 |
| Tamoxifen Citrate | 69 | $3,570 | $52 |
| Hydroxyurea | 69 | $3,239 | $47 |
| Spironolactone-Hctz | 51 | $2,644 | $52 |
| Atorvastatin | 107 | $1,787 | $17 |
| Glipizide | 25 | $1,138 | $46 |
| Metformin | 97 | $1,094 | $11 |
| Albuterol Sulfate Hfa | 29 | $924 | $32 |
| Losartan | 71 | $895 | $13 |
| Triamcinolone Acetonide | 40 | $687 | $17 |
| Metoprolol | 35 | $602 | $17 |
| Omeprazole | 23 | $501 | $22 |
| Amlodipine Besylate | 49 | $411 | $8 |
| Tamsulosin | 17 | $381 | $22 |
| Glipizide Er | 12 | $359 | $30 |
| Prednisone | 30 | $348 | $12 |
| Allopurinol | 20 | $315 | $16 |
| Clopidogrel | 13 | $290 | $22 |
| Famotidine | 13 | $230 | $18 |
| Alendronate | 12 | $217 | $18 |
| Lovastatin | 11 | $153 | $14 |
| Atenolol | 26 | $151 | $6 |
| Hydrochlorothiazide | 19 | $121 | $6 |
| Pantoprazole | 12 | $118 | $10 |
| Acetaminophen-Codeine | 11 | $89 | $8 |
| Ibuprofen | 11 | $80 | $7 |
| Lisinopril | 14 | $66 | $5 |
2021: 32 drugs
| Imbruvica | 14 | $223,506 | $15,965 |
| Imatinib Mesylate | 24 | $53,248 | $2,219 |
| Jardiance | 14 | $9,667 | $690 |
| Tamoxifen Citrate | 71 | $3,499 | $49 |
| Hydroxyurea | 65 | $3,252 | $50 |
| Spironolactone-Hctz | 32 | $1,911 | $60 |
| Atorvastatin | 90 | $1,292 | $14 |
| Glipizide | 25 | $941 | $38 |
| Metoprolol | 36 | $880 | $24 |
| Losartan | 62 | $849 | $14 |
| Metformin | 81 | $817 | $10 |
| Albuterol Sulfate Hfa | 24 | $785 | $33 |
| Amlodipine Besylate | 51 | $486 | $10 |
| Allopurinol | 23 | $396 | $17 |
| Terazosin | 11 | $353 | $32 |
| Lovastatin | 25 | $328 | $13 |
| Omeprazole | 15 | $314 | $21 |
| Triamcinolone Acetonide | 30 | $308 | $10 |
| Glipizide Er | 12 | $285 | $24 |
| Levothyroxine | 12 | $281 | $23 |
| Alendronate | 15 | $263 | $18 |
| Prednisone | 19 | $242 | $13 |
| Pantoprazole | 12 | $205 | $17 |
| Famotidine | 14 | $180 | $13 |
| Ibuprofen | 17 | $153 | $9 |
| Lisinopril | 27 | $149 | $6 |
| Atenolol | 19 | $146 | $8 |
| Clopidogrel | 11 | $137 | $12 |
| Tamsulosin | 14 | $115 | $8 |
| Simvastatin | 12 | $110 | $9 |
| Finasteride | 11 | $97 | $9 |
| Hydrochlorothiazide | 14 | $81 | $6 |
2020: 26 drugs
| Xalkori | 12 | $239,776 | $19,981 |
| Tarceva | 16 | $194,663 | $12,166 |
| Imatinib Mesylate | 29 | $8,151 | $281 |
| Jardiance | 12 | $6,197 | $516 |
| Tamoxifen Citrate | 81 | $4,440 | $55 |
| Hydroxyurea | 66 | $3,849 | $58 |
| Spironolactone-Hctz | 41 | $2,852 | $70 |
| Atorvastatin | 74 | $1,491 | $20 |
| Losartan | 74 | $814 | $11 |
| Metformin | 77 | $739 | $10 |
| Metoprolol | 29 | $686 | $24 |
| Glipizide | 21 | $658 | $31 |
| Amlodipine Besylate | 52 | $419 | $8 |
| Triamcinolone Acetonide | 27 | $357 | $13 |
| Prednisone | 30 | $332 | $11 |
| Lovastatin | 20 | $264 | $13 |
| Omeprazole | 26 | $251 | $10 |
| Allopurinol | 17 | $248 | $15 |
| Acetaminophen-Codeine | 11 | $215 | $20 |
| Glipizide Er | 12 | $214 | $18 |
| Tamsulosin | 20 | $199 | $10 |
| Finasteride | 15 | $178 | $12 |
| Famotidine | 13 | $172 | $13 |
| Atenolol | 21 | $130 | $6 |
| Simvastatin | 12 | $126 | $10 |
| Lisinopril | 15 | $87 | $6 |
2019: 30 drugs
| Tarceva | 33 | $316,823 | $9,601 |
| Xalkori | 11 | $200,302 | $18,209 |
| Imatinib Mesylate | 20 | $10,194 | $510 |
| Tamoxifen Citrate | 82 | $5,207 | $64 |
| Hydroxyurea | 59 | $3,676 | $62 |
| Spironolactone-Hctz | 34 | $2,169 | $64 |
| Atorvastatin | 64 | $1,600 | $25 |
| Metoprolol | 39 | $1,574 | $40 |
| Losartan | 95 | $1,087 | $11 |
| Metformin | 83 | $874 | $11 |
| Hydrocodone-Acetaminophen | 31 | $855 | $28 |
| Glipizide | 46 | $831 | $18 |
| Omeprazole | 25 | $527 | $21 |
| Amlodipine Besylate | 57 | $485 | $9 |
| Triamcinolone Acetonide | 42 | $481 | $11 |
| Atenolol | 19 | $474 | $25 |
| Allopurinol | 21 | $442 | $21 |
| Lovastatin | 18 | $441 | $25 |
| Prednisone | 37 | $392 | $11 |
| Lisinopril | 18 | $347 | $19 |
| Pantoprazole | 13 | $329 | $25 |
| Acetaminophen-Codeine | 15 | $292 | $19 |
| Glipizide Er | 12 | $266 | $22 |
| Simvastatin | 16 | $262 | $16 |
| Metoprolol | 11 | $210 | $19 |
| Prochlorperazine Maleate | 14 | $183 | $13 |
| Tamsulosin | 17 | $174 | $10 |
| Finasteride | 15 | $156 | $10 |
| Ibuprofen | 12 | $122 | $10 |
| Hydrochlorothiazide | 14 | $49 | $3 |
2018: 35 drugs
| Tarceva | 34 | $327,010 | $9,618 |
| Sutent | 11 | $194,158 | $17,651 |
| Xalkori | 11 | $190,765 | $17,342 |
| Revlimid | 13 | $173,359 | $13,335 |
| Imatinib Mesylate | 14 | $21,509 | $1,536 |
| Tamoxifen Citrate | 74 | $4,176 | $56 |
| Hydroxyurea | 65 | $4,014 | $62 |
| Spironolactone-Hctz | 41 | $2,603 | $63 |
| Atorvastatin | 52 | $1,524 | $29 |
| Metoprolol | 30 | $1,497 | $50 |
| Losartan | 105 | $1,084 | $10 |
| Metformin | 83 | $942 | $11 |
| Glipizide | 51 | $942 | $18 |
| Allopurinol | 23 | $578 | $25 |
| Lovastatin | 22 | $557 | $25 |
| Simvastatin | 31 | $534 | $17 |
| Amlodipine Besylate | 42 | $471 | $11 |
| Hydrocodone-Acetaminophen | 23 | $445 | $19 |
| Glipizide Er | 18 | $425 | $24 |
| Lisinopril | 22 | $383 | $17 |
| Dexamethasone | 12 | $349 | $29 |
| Anastrozole | 11 | $335 | $30 |
| Prednisone | 32 | $320 | $10 |
| Triamcinolone Acetonide | 35 | $318 | $9 |
| Tamsulosin | 17 | $261 | $15 |
| Acetaminophen-Codeine | 16 | $248 | $15 |
| Omeprazole | 27 | $237 | $9 |
| Atenolol | 21 | $218 | $10 |
| Prochlorperazine Maleate | 13 | $157 | $12 |
| Hydrochlorothiazide | 16 | $144 | $9 |
| Finasteride | 11 | $114 | $10 |
| Ibuprofen | 17 | $110 | $6 |
| Metoprolol | 15 | $106 | $7 |
| Cephalexin | 14 | $97 | $7 |
| Azithromycin | 11 | $90 | $8 |
2017: 30 drugs
| Tarceva | 31 | $337,834 | $10,898 |
| Revlimid | 22 | $219,369 | $9,971 |
| Tamoxifen Citrate | 77 | $3,909 | $51 |
| Hydroxyurea | 53 | $3,772 | $71 |
| Spironolactone-Hctz | 30 | $1,971 | $66 |
| Atorvastatin | 49 | $1,295 | $26 |
| Metoprolol | 27 | $1,251 | $46 |
| Glipizide | 66 | $1,140 | $17 |
| Losartan | 83 | $972 | $12 |
| Metformin | 68 | $738 | $11 |
| Lovastatin | 21 | $630 | $30 |
| Amlodipine Besylate | 41 | $497 | $12 |
| Simvastatin | 19 | $435 | $23 |
| Omeprazole | 29 | $426 | $15 |
| Allopurinol | 24 | $405 | $17 |
| Anastrozole | 17 | $368 | $22 |
| Gabapentin | 17 | $336 | $20 |
| Triamcinolone Acetonide | 36 | $335 | $9 |
| Glipizide Er | 14 | $334 | $24 |
| Tamsulosin | 18 | $333 | $18 |
| Pantoprazole | 17 | $261 | $15 |
| Diphenoxylate-Atropine | 12 | $260 | $22 |
| Ibuprofen | 27 | $252 | $9 |
| Dexamethasone | 22 | $240 | $11 |
| Prednisone | 21 | $205 | $10 |
| Lisinopril | 19 | $201 | $11 |
| Atenolol | 13 | $182 | $14 |
| Acetaminophen-Codeine | 14 | $158 | $11 |
| Hydrochlorothiazide | 19 | $140 | $7 |
| Azithromycin | 11 | $66 | $6 |
2016: 36 drugs
| Tarceva | 31 | $321,115 | $10,359 |
| Revlimid | 27 | $288,272 | $10,677 |
| Hydroxyurea | 58 | $4,122 | $71 |
| Tamoxifen Citrate | 83 | $3,857 | $46 |
| Spironolactone-Hctz | 47 | $3,386 | $72 |
| Metoprolol | 31 | $1,545 | $50 |
| Celecoxib | 13 | $1,445 | $111 |
| Glipizide | 92 | $1,232 | $13 |
| Atorvastatin | 54 | $1,163 | $22 |
| Losartan | 78 | $851 | $11 |
| Triamcinolone Acetonide | 31 | $774 | $25 |
| Anastrozole | 50 | $668 | $13 |
| Allopurinol | 32 | $664 | $21 |
| Metformin | 80 | $645 | $8 |
| Omeprazole | 59 | $630 | $11 |
| Levothyroxine | 18 | $608 | $34 |
| Hydrocodone-Acetaminophen | 18 | $496 | $28 |
| Glipizide Er | 16 | $407 | $25 |
| Acetaminophen-Codeine | 25 | $358 | $14 |
| Gabapentin | 21 | $354 | $17 |
| Prednisone | 29 | $332 | $11 |
| Simvastatin | 55 | $325 | $6 |
| Lovastatin | 23 | $319 | $14 |
| Amlodipine Besylate | 63 | $295 | $5 |
| Valsartan | 11 | $278 | $25 |
| Dexamethasone | 18 | $268 | $15 |
| Ibuprofen | 37 | $259 | $7 |
| Lisinopril | 31 | $211 | $7 |
| Metoprolol | 27 | $211 | $8 |
| Clopidogrel | 17 | $177 | $10 |
| Prochlorperazine Maleate | 16 | $146 | $9 |
| Alendronate | 11 | $141 | $13 |
| Atenolol | 24 | $139 | $6 |
| Hydrochlorothiazide | 24 | $125 | $5 |
| Cephalexin | 18 | $102 | $6 |
| Zolpidem | 15 | $87 | $6 |
2015: 41 drugs
| Tarceva | 28 | $212,652 | $7,595 |
| Revlimid | 15 | $199,061 | $13,271 |
| Zytiga | 12 | $97,525 | $8,127 |
| Sprycel | 12 | $61,669 | $5,139 |
| Spironolactone-Hctz | 71 | $4,978 | $70 |
| Lantus | 11 | $4,181 | $380 |
| Hydroxyurea | 63 | $3,197 | $51 |
| Tamoxifen Citrate | 56 | $2,918 | $52 |
| Celecoxib | 12 | $1,829 | $152 |
| Glipizide | 112 | $1,593 | $14 |
| Metoprolol | 31 | $1,316 | $42 |
| Triamcinolone Acetonide | 46 | $1,259 | $27 |
| Levothyroxine | 26 | $964 | $37 |
| Anastrozole | 47 | $924 | $20 |
| Atorvastatin | 44 | $904 | $21 |
| Allopurinol | 37 | $737 | $20 |
| Tamsulosin | 14 | $717 | $51 |
| Losartan | 62 | $698 | $11 |
| Omeprazole | 52 | $637 | $12 |
| Metformin | 75 | $515 | $7 |
| Simvastatin | 77 | $498 | $6 |
| Prednisone | 31 | $476 | $15 |
| Clopidogrel | 33 | $450 | $14 |
| Lovastatin | 35 | $439 | $13 |
| Glipizide Er | 15 | $379 | $25 |
| Amlodipine Besylate | 55 | $379 | $7 |
| Theophylline Anhydrous | 11 | $366 | $33 |
| Ibuprofen | 41 | $360 | $9 |
| Hydrocodone-Acetaminophen | 12 | $352 | $29 |
| Potassium Chloride | 11 | $348 | $32 |
| Metoprolol | 43 | $298 | $7 |
| Meclizine | 12 | $279 | $23 |
| Lisinopril | 43 | $244 | $6 |
| Alendronate | 16 | $207 | $13 |
| Atenolol | 44 | $190 | $4 |
| Cephalexin | 26 | $165 | $6 |
| Acetaminophen-Codeine | 11 | $150 | $14 |
| Azithromycin | 14 | $129 | $9 |
| Hydrochlorothiazide | 23 | $121 | $5 |
| Prochlorperazine Maleate | 12 | $88 | $7 |
| Lorazepam | 13 | $82 | $6 |
2014: 47 drugs
| Tarceva | 52 | $456,110 | $8,771 |
| Revlimid | 11 | $100,434 | $9,130 |
| Zytiga | 12 | $88,439 | $7,370 |
| Diovan | 11 | $5,208 | $473 |
| Hydroxyurea | 71 | $4,584 | $65 |
| Spironolactone-Hctz | 66 | $3,839 | $58 |
| Tamoxifen Citrate | 58 | $2,712 | $47 |
| Colcrys | 12 | $2,585 | $215 |
| Celebrex | 11 | $2,281 | $207 |
| Glipizide | 99 | $1,669 | $17 |
| Anastrozole | 60 | $1,495 | $25 |
| Metoprolol | 24 | $1,369 | $57 |
| Triamcinolone Acetonide | 41 | $1,150 | $28 |
| Atorvastatin | 41 | $1,095 | $27 |
| Felodipine Er | 13 | $919 | $71 |
| Simvastatin | 95 | $870 | $9 |
| Hydrocodone-Acetaminophen | 20 | $790 | $39 |
| Levothyroxine | 21 | $734 | $35 |
| Digox | 16 | $721 | $45 |
| Omeprazole | 56 | $689 | $12 |
| Lovastatin | 39 | $672 | $17 |
| Metformin | 66 | $656 | $10 |
| Clopidogrel | 32 | $541 | $17 |
| Losartan | 31 | $485 | $16 |
| Metoprolol | 65 | $461 | $7 |
| Prednisone | 33 | $452 | $14 |
| Lisinopril | 52 | $425 | $8 |
| Tamsulosin | 18 | $411 | $23 |
| Amlodipine Besylate | 55 | $346 | $6 |
| Alendronate | 27 | $333 | $12 |
| Allopurinol | 35 | $333 | $10 |
| Atenolol | 54 | $268 | $5 |
| Triamterene-Hydrochlorothiazid | 12 | $267 | $22 |
| Theophylline Anhydrous | 16 | $265 | $17 |
| Meclizine | 13 | $261 | $20 |
| Cephalexin | 31 | $236 | $8 |
| Amlodipine Besylate-Benazepril | 12 | $233 | $19 |
| Ibuprofen | 30 | $231 | $8 |
| Hydrochlorothiazide | 26 | $194 | $7 |
| Acetaminophen-Codeine | 12 | $186 | $15 |
| Carvedilol | 11 | $142 | $13 |
| Terazosin | 13 | $131 | $10 |
| Prochlorperazine Maleate | 17 | $126 | $7 |
| Isosorbide Mononitrate Er | 12 | $103 | $9 |
| Dexamethasone | 11 | $97 | $9 |
| Finasteride | 12 | $94 | $8 |
| Lorazepam | 19 | $73 | $4 |
2013: 45 drugs
| Tarceva | 74 | $433,451 | $5,857 |
| Nexavar | 12 | $87,468 | $7,289 |
| Promacta | 19 | $73,218 | $3,854 |
| Sprycel | 12 | $56,560 | $4,713 |
| Hydroxyurea | 90 | $5,121 | $57 |
| Aggrenox | 14 | $3,759 | $268 |
| Diovan | 11 | $3,602 | $327 |
| Colcrys | 13 | $3,454 | $266 |
| Spironolactone-Hctz | 107 | $3,277 | $31 |
| Tamoxifen Citrate | 80 | $2,705 | $34 |
| Glyburide | 40 | $2,165 | $54 |
| Triamcinolone Acetonide | 68 | $1,918 | $28 |
| Anastrozole | 73 | $1,895 | $26 |
| Atorvastatin | 33 | $1,287 | $39 |
| Glipizide | 89 | $1,160 | $13 |
| Gabapentin | 12 | $938 | $78 |
| Amlodipine Besylate | 82 | $927 | $11 |
| Metoprolol | 13 | $870 | $67 |
| Simvastatin | 73 | $842 | $12 |
| Metoprolol | 90 | $799 | $9 |
| Lovastatin | 54 | $750 | $14 |
| Clopidogrel | 41 | $686 | $17 |
| Metformin | 61 | $625 | $10 |
| Omeprazole | 51 | $567 | $11 |
| Megestrol Acetate | 12 | $540 | $45 |
| Losartan | 26 | $447 | $17 |
| Levothyroxine | 23 | $431 | $19 |
| Atenolol | 68 | $412 | $6 |
| Pravastatin | 22 | $404 | $18 |
| Meclizine | 17 | $386 | $23 |
| Ibuprofen | 57 | $385 | $7 |
| Lisinopril | 48 | $367 | $8 |
| Acetaminophen-Codeine | 22 | $366 | $17 |
| Prednisone | 51 | $347 | $7 |
| Alendronate | 25 | $279 | $11 |
| Tamsulosin | 17 | $275 | $16 |
| Cephalexin | 28 | $246 | $9 |
| Allopurinol | 55 | $243 | $4 |
| Hydrocodone-Acetaminophen | 17 | $211 | $12 |
| Hydrochlorothiazide | 25 | $199 | $8 |
| Famotidine | 22 | $168 | $8 |
| Lorazepam | 21 | $152 | $7 |
| Pantoprazole | 11 | $138 | $13 |
| Prochlorperazine Maleate | 19 | $129 | $7 |
| Digox | 14 | $92 | $7 |
Money from drug and device companies
$1,188 in 2025
| 2025 | 17 | 42 | None | $1,188 |
| 2024 | 21 | 47 | None | $1,460 |
| 2023 | 14 | 44 | None | $1,540 |
| 2022 | 16 | 45 | None | $1,170 |
| 2021 | 5 | 12 | None | $625 |
| 2020 | 2 | 3 | None | $82 |
| 2019 | 5 | 16 | $3,720 | $4,358 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Calquence | $415 | 12 payments
|
| Agios Pharmaceuticals | Pyrukynd | $104 | 3 payments
|
| Regeneron Healthcare Solutions | Libtayo | $78 | 2 payments
|
| Merck Sharp & Dohme | Keytruda | $63 | 2 payments
|
| Travere Therapeutics | None | $62 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $61 | 2 payments
|
See all 39 published payments
| Travere Therapeutics | Meals · 2025-11-07 | None | $34 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-03 | Tagrisso | $27 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-24 | None | $31 |
| Regeneron Healthcare Solutions | Meals · 2025-10-24 | Libtayo | $38 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-09 | None | $33 |
| Merck Sharp & Dohme | Meals · 2025-10-03 | Keytruda | $31 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-09-22 | Opdivo | $30 |
| Agios Pharmaceuticals | Meals · 2025-09-15 | Pyrukynd | $32 |
| Merck Sharp & Dohme | Meals · 2025-09-12 | Keytruda | $31 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-25 | Calquence | $26 |
| Exact Sciences | Meals · 2025-08-22 | Cologuard Collection Kit | $22 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-18 | Calquence | $38 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-15 | None | $30 |
| Regeneron Healthcare Solutions | Meals · 2025-08-08 | Libtayo | $40 |
| Agios Pharmaceuticals | Meals · 2025-08-04 | Pyrukynd | $38 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-07-28 | Opdivo | $31 |
| Janssen Biotech | Meals · 2025-07-21 | Erleada | $22 |
| Lilly USA | Meals · 2025-07-18 | Jaypirca | $30 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-07-01 | Kerendia | $24 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-27 | Tagrisso | $22 |
| Travere Therapeutics | Meals · 2025-06-06 | None | $29 |
| Array Biopharma | Meals · 2025-06-02 | Xalkori | $31 |
| Lilly USA | Meals · 2025-05-23 | Jaypirca | $16 |
| Novocure | Meals · 2025-05-19 | Optune Lua (Novottf-200t) | $19 |
| Janssen Biotech | Meals · 2025-05-12 | Erleada | $29 |
| Celgene | Meals · 2025-05-09 | Opdivo | $32 |
| AstraZeneca Pharmaceuticals LP | Education · 2025-04-28 | None | $93 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-28 | Calquence | $30 |
| Eisai | Meals · 2025-04-25 | Lenvima | $27 |
| Celgene | Meals · 2025-04-18 | Opdivo | $24 |
| Astellas Pharma US | Meals · 2025-04-05 | Vyloy | $29 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-03-22 | Kerendia | $29 |
| Agios Pharmaceuticals | Meals · 2025-03-17 | Pyrukynd | $34 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-26 | Calquence | $30 |
| Novartis Pharmaceuticals | Meals · 2025-02-24 | Kisqali | $27 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-07 | Tagrisso | $23 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-06 | Lynparza | $32 |
| Array Biopharma | Meals · 2025-01-17 | Xalkori | $21 |
| Coherus Oncology | Meals · 2025-01-13 | Loqtorzi | $22 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,460
| AstraZeneca Pharmaceuticals LP | Tagrisso | $458 | 14 payments
|
| Janssen Pharmaceuticals | Xarelto | $152 | 2 payments
|
| Coherus Biosciences | Udenyca | $93 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $84 | 4 payments
|
| Merck Sharp & Dohme | Keytruda | $77 | 3 payments
|
| Regeneron Healthcare Solutions | Libtayo | $73 | 2 payments
|
| Dynavax Technologies | Heplisav-B | $67 | 1 payment
|
| Janssen Biotech | Rybrevant | $56 | 2 payments
|
| Amgen | Aranesp | $54 | 2 payments
|
| Astellas Pharma US | Vyloy | $48 | 2 payments
|
| Eisai | Lenvima | $45 | 2 payments
|
| GlaxoSmithKline | Ojjaara | $33 | 1 payment
|
| Geron | Rytelo | $33 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $32 | 1 payment
|
| Agios Pharmaceuticals | None | $28 | 1 payment
|
| Rigel Pharmaceuticals | Rezlidhia | $25 | 1 payment
|
| Novartis Pharmaceuticals | Pluvicto | $24 | 1 payment
|
| Novocure | Optune Lua (Novottf-200t) | $22 | 1 payment
|
| Celgene | Pomalyst | $21 | 1 payment
|
| Gilead Sciences | None | $21 | 1 payment
|
| Lilly USA | Jaypirca | $15 | 1 payment
|
2023: $1,540
| AstraZeneca Pharmaceuticals LP | Enhertu | $504 | 13 payments
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $324 | 8 payments
|
| Merck Sharp & Dohme | Keytruda | $183 | 3 payments
|
| Gilead Sciences | Vemlidy | $121 | 1 payment
|
| Janssen Biotech | Rybrevant | $71 | 3 payments
|
| Rigel Pharmaceuticals | Rezlidhia | $64 | 3 payments
|
| GlaxoSmithKline | Zejula | $61 | 2 payments
|
| Regeneron Healthcare Solutions | Libtayo | $57 | 2 payments
|
| Astellas Pharma US | None | $31 | 1 payment
|
| Eisai | Lenvima | $30 | 1 payment
|
| Amgen | Vectibix | $28 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $23 | 1 payment
|
| Lilly USA | Verzenio | $21 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Alunbrig | $20 | 1 payment
|
2022: $1,170
| AstraZeneca Pharmaceuticals LP | Imfinzi | $241 | 8 payments
|
| Takeda Pharmaceuticals U.S.A. | Ninlaro | $165 | 7 payments
|
| Lilly USA | Verzenio | $155 | 8 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $119 | 1 payment
|
| Genzyme | Libtayo | $118 | 1 payment
|
| Rigel Pharmaceuticals | Tavalisse | $82 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $50 | 2 payments
|
| GlaxoSmithKline | Zejula | $46 | 2 payments
|
| Regeneron Healthcare Solutions | Libtayo | $33 | 1 payment
|
| Amgen | Xgeva | $30 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | None | $25 | 1 payment
|
| MorphoSys US | Monjuvi | $25 | 1 payment
|
| Gilead Sciences | Trodelvy | $24 | 1 payment
|
| Eisai | Lenvima | $21 | 1 payment
|
| Merck Sharp & Dohme | Keytruda | $20 | 1 payment
|
| Daiichi Sankyo | Enhertu | $15 | 1 payment
|
2021: $625
| Epizyme | Tazverik | $208 | 2 payments
|
| GlaxoSmithKline | Zejula | $141 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Alunbrig | $104 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | None | $97 | 2 payments
|
| Lilly USA | None | $75 | 1 payment
|
2020: $82
| Takeda Pharmaceuticals U.S.A. | Alunbrig | $68 | 2 payments
|
| Dova Pharmaceuticals | Doptelet | $15 | 1 payment
|
2019: $4,358
| AstraZeneca Pharmaceuticals LP | Tagrisso | $2,357 | 3 payments
|
| Bayer HealthCare Pharmaceuticals | Vitrakvi | $1,653 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $167 | 7 payments
|
| Gilead Sciences | None | $110 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $72 | 1 payment
|
Professional record
- NPI
- 1033155213
- Licence
- CA 00G307720
- Trained
- University of California, San Francisco School of Medicine, 1974 · 52 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RH0003X (207RH0003X); Internal medicine (207R00000X)
- Mailing address
- 728 Pacific Ave, San Francisco, CA, 94133
- NPI first listed
- 2006-06-22
- NPI last updated
- 2025-09-11
This is when the NPI record was last certified, not a medical board exam.